Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-31

FDA Approved: VALPROIC ACID — Supplemental Application (Xttrium Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for VALPROIC ACID from Xttrium Laboratories Inc. The approval concerns changes to the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALPROIC ACID (Valproic acid)

Snippet

SUPPL AP for VALPROIC ACID (VALPROIC ACID)